_id
6911bd16ccc777a4e85d624c
Ticker
GLMD
Name
Galmed Pharmaceuticals Ltd
Exchange
NASDAQ
Address
16 Abba Hillel Road, Ramat Gan, Israel, 5250608
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://galmedpharma.com
Description
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
Last Close
1.03
Volume
61696
Current Price
1.05
Change
1.9417475728155356
Last Updated
2025-11-30T19:24:54.451Z
Image
data:image/webp;base64,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
Ipo Date
2014-03-13T00:00:00.000Z
Market Cap
5149930
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9695
Sentiment Sources
2
Rating
3
Target Price
12
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2109000
Operating Income
-2109000
Interest Expense
-
Pretax Income
-2495000
Net Income
-2495000
Eps
-0.6319351398995489
Dividends Per Share
-
Shares Outstanding
5479231
Income Tax Expense
-
EBITDA
-2109000
Operating Margin
-
Total Other Income Expense Net
-386000
Cash
4964000
Short Term Investments
15564000
Receivables
433000
Inventories
-
Total Current Assets
21084000
Property Plant Equipment
-
Total Assets
22944000
Payables
1369000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2421000
Equity
20523000
Depreciation
0
Change In Working Capital
628000
Cash From Operations
-1268000
Capital Expenditures
0
Cash From Investing
-4569000
Cash From Financing
6035000
Net Change In Cash
198000
PE
-
PB
0.20199773424937875
ROE
-12.157092043073625
ROA
-10.874302649930264
FCF
-1268000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
7.5
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2109000
Quarters > 0 > income Statement > operating Income
-2109000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2495000
Quarters > 0 > income Statement > net Income
-2495000
Quarters > 0 > income Statement > eps
-0.6319351398995489
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3948190
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2109000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-386000
Quarters > 0 > balance Sheet > cash
4964000
Quarters > 0 > balance Sheet > short Term Investments
15564000
Quarters > 0 > balance Sheet > receivables
433000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
21084000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
22944000
Quarters > 0 > balance Sheet > payables
1369000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2421000
Quarters > 0 > balance Sheet > equity
20523000
Quarters > 0 > cash Flow > net Income
-2495000
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
628000
Quarters > 0 > cash Flow > cash From Operations
-1268000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-4569000
Quarters > 0 > cash Flow > cash From Financing
6035000
Quarters > 0 > cash Flow > net Change In Cash
198000
Quarters > 0 > ratios > PE
-0.6319351398995489
Quarters > 0 > ratios > PB
0.20199773424937875
Quarters > 0 > ratios > ROE
-12.157092043073625
Quarters > 0 > ratios > ROA
-10.874302649930264
Quarters > 0 > ratios > FCF
-1268000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1264000
Quarters > 1 > income Statement > operating Income
-1264000
Quarters > 1 > income Statement > interest Expense
448000
Quarters > 1 > income Statement > pretax Income
-1104000
Quarters > 1 > income Statement > net Income
-1104000
Quarters > 1 > income Statement > eps
-0.6203310117744895
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1779695
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1264000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
160000
Quarters > 1 > balance Sheet > cash
4767000
Quarters > 1 > balance Sheet > short Term Investments
10962000
Quarters > 1 > balance Sheet > receivables
447000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
16298000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
18684000
Quarters > 1 > balance Sheet > payables
1308000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1807000
Quarters > 1 > balance Sheet > equity
16877000
Quarters > 1 > cash Flow > net Income
-1104000
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
-141000
Quarters > 1 > cash Flow > cash From Operations
-1167000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-231000
Quarters > 1 > cash Flow > cash From Financing
1514000
Quarters > 1 > cash Flow > net Change In Cash
116000
Quarters > 1 > ratios > PE
-0.6203310117744895
Quarters > 1 > ratios > PB
0.11072345499792617
Quarters > 1 > ratios > ROE
-6.541446939621971
Quarters > 1 > ratios > ROA
-5.908798972382788
Quarters > 1 > ratios > FCF
-1167000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1644000
Quarters > 2 > income Statement > operating Income
-1644000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3209000
Quarters > 2 > income Statement > net Income
-3209000
Quarters > 2 > income Statement > eps
-1.9274616129412019
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1664884
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
4652000
Quarters > 2 > balance Sheet > short Term Investments
10679000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
16124000
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
18500000
Quarters > 2 > balance Sheet > payables
1308000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2173000
Quarters > 2 > balance Sheet > equity
16327000
Quarters > 2 > cash Flow > net Income
-3209000
Quarters > 2 > cash Flow > depreciation
0
Quarters > 2 > cash Flow > change In Working Capital
-580000
Quarters > 2 > cash Flow > cash From Operations
-1969000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
448000
Quarters > 2 > cash Flow > net Change In Cash
-5070000
Quarters > 2 > ratios > PE
-1.9274616129412019
Quarters > 2 > ratios > PB
0.10706977399399768
Quarters > 2 > ratios > ROE
-19.65455993140197
Quarters > 2 > ratios > ROA
-17.345945945945946
Quarters > 2 > ratios > FCF
-1969000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2011000
Quarters > 3 > income Statement > operating Income
-2011000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1914000
Quarters > 3 > income Statement > net Income
-1914000
Quarters > 3 > income Statement > eps
-27.688969258589513
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
69125
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2011000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
97000
Quarters > 3 > balance Sheet > cash
9724000
Quarters > 3 > balance Sheet > short Term Investments
7416000
Quarters > 3 > balance Sheet > receivables
426000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
17685000
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
20950000
Quarters > 3 > balance Sheet > payables
1342000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2514000
Quarters > 3 > balance Sheet > equity
18436000
Quarters > 3 > cash Flow > net Income
-1914000
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
669000
Quarters > 3 > cash Flow > cash From Operations
-1064000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
614000
Quarters > 3 > cash Flow > cash From Financing
8338000
Quarters > 3 > cash Flow > net Change In Cash
7888000
Quarters > 3 > ratios > PE
-27.688969258589513
Quarters > 3 > ratios > PB
0.003936930462139293
Quarters > 3 > ratios > ROE
-10.381861575178998
Quarters > 3 > ratios > ROA
-9.136038186157517
Quarters > 3 > ratios > FCF
-1064000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
83000
Annuals > 0 > income Statement > gross Profit
-83000
Annuals > 0 > income Statement > operating Expenses
6195000
Annuals > 0 > income Statement > operating Income
-6278000
Annuals > 0 > income Statement > interest Expense
15000
Annuals > 0 > income Statement > pretax Income
-7517000
Annuals > 0 > income Statement > net Income
-7517000
Annuals > 0 > income Statement > eps
-8.075657859397392
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
930822
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-7419000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1239000
Annuals > 0 > balance Sheet > cash
4652000
Annuals > 0 > balance Sheet > short Term Investments
10679000
Annuals > 0 > balance Sheet > receivables
209000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
16124000
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
18500000
Annuals > 0 > balance Sheet > payables
1308000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2173000
Annuals > 0 > balance Sheet > equity
16327000
Annuals > 0 > cash Flow > net Income
-7517000
Annuals > 0 > cash Flow > depreciation
83000
Annuals > 0 > cash Flow > change In Working Capital
-728000
Annuals > 0 > cash Flow > cash From Operations
-5880000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-1111000
Annuals > 0 > cash Flow > cash From Financing
8786000
Annuals > 0 > cash Flow > net Change In Cash
1795000
Annuals > 0 > ratios > PE
-8.075657859397392
Annuals > 0 > ratios > PB
0.05358483480124946
Annuals > 0 > ratios > ROE
-46.04030134133644
Annuals > 0 > ratios > ROA
-40.63243243243243
Annuals > 0 > ratios > FCF
-5880000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
31000
Annuals > 1 > income Statement > gross Profit
-31000
Annuals > 1 > income Statement > operating Expenses
-7492000
Annuals > 1 > income Statement > operating Income
7492000
Annuals > 1 > income Statement > interest Expense
11000
Annuals > 1 > income Statement > pretax Income
-6912000
Annuals > 1 > income Statement > net Income
-6912000
Annuals > 1 > income Statement > eps
-29.94878549702332
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
230794
Annuals > 1 > income Statement > income Tax Expense
-14984000
Annuals > 1 > income Statement > EBITDA
-6870000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-14404000
Annuals > 1 > balance Sheet > cash
2861000
Annuals > 1 > balance Sheet > short Term Investments
9781000
Annuals > 1 > balance Sheet > receivables
165000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
13239000
Annuals > 1 > balance Sheet > property Plant Equipment
125000
Annuals > 1 > balance Sheet > total Assets
16629000
Annuals > 1 > balance Sheet > payables
1879000
Annuals > 1 > balance Sheet > short Term Debt
41000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2750000
Annuals > 1 > balance Sheet > equity
13879000
Annuals > 1 > cash Flow > net Income
-6912000
Annuals > 1 > cash Flow > depreciation
31000
Annuals > 1 > cash Flow > change In Working Capital
132000
Annuals > 1 > cash Flow > cash From Operations
-6137000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
800000
Annuals > 1 > cash Flow > cash From Financing
6185000
Annuals > 1 > cash Flow > net Change In Cash
848000
Annuals > 1 > ratios > PE
-29.94878549702332
Annuals > 1 > ratios > PB
0.01562960448159089
Annuals > 1 > ratios > ROE
-49.801858923553574
Annuals > 1 > ratios > ROA
-41.56593902219015
Annuals > 1 > ratios > FCF
-6137000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
35000
Annuals > 2 > income Statement > gross Profit
-35000
Annuals > 2 > income Statement > operating Expenses
17651000
Annuals > 2 > income Statement > operating Income
-17651000
Annuals > 2 > income Statement > interest Expense
215000
Annuals > 2 > income Statement > pretax Income
-17866000
Annuals > 2 > income Statement > net Income
-18571000
Annuals > 2 > income Statement > eps
-11.079345798964551
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1676182
Annuals > 2 > income Statement > income Tax Expense
705000
Annuals > 2 > income Statement > EBITDA
-17616000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-215000
Annuals > 2 > balance Sheet > cash
2016000
Annuals > 2 > balance Sheet > short Term Investments
11769000
Annuals > 2 > balance Sheet > receivables
124000
Annuals > 2 > balance Sheet > inventories
114000
Annuals > 2 > balance Sheet > total Current Assets
14724000
Annuals > 2 > balance Sheet > property Plant Equipment
337000
Annuals > 2 > balance Sheet > total Assets
16561000
Annuals > 2 > balance Sheet > payables
2560000
Annuals > 2 > balance Sheet > short Term Debt
171000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3138000
Annuals > 2 > balance Sheet > equity
13423000
Annuals > 2 > cash Flow > net Income
-17866000
Annuals > 2 > cash Flow > depreciation
35000
Annuals > 2 > cash Flow > change In Working Capital
-2451000
Annuals > 2 > cash Flow > cash From Operations
-18501000
Annuals > 2 > cash Flow > capital Expenditures
4000
Annuals > 2 > cash Flow > cash From Investing
17563000
Annuals > 2 > cash Flow > cash From Financing
70000
Annuals > 2 > cash Flow > net Change In Cash
-868000
Annuals > 2 > ratios > PE
-11.079345798964551
Annuals > 2 > ratios > PB
0.11736895342322878
Annuals > 2 > ratios > ROE
-138.35208224688967
Annuals > 2 > ratios > ROA
-112.13694825191716
Annuals > 2 > ratios > FCF
-18505000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
42000
Annuals > 3 > income Statement > gross Profit
-42000
Annuals > 3 > income Statement > operating Expenses
32881000
Annuals > 3 > income Statement > operating Income
-32881000
Annuals > 3 > income Statement > interest Expense
43000
Annuals > 3 > income Statement > pretax Income
-32467000
Annuals > 3 > income Statement > net Income
-31948000
Annuals > 3 > income Statement > eps
-19.482364764410228
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1639842
Annuals > 3 > income Statement > income Tax Expense
-519000
Annuals > 3 > income Statement > EBITDA
-32839000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
414000
Annuals > 3 > balance Sheet > cash
2884000
Annuals > 3 > balance Sheet > short Term Investments
31931000
Annuals > 3 > balance Sheet > receivables
79000
Annuals > 3 > balance Sheet > inventories
-932000
Annuals > 3 > balance Sheet > total Current Assets
36054000
Annuals > 3 > balance Sheet > property Plant Equipment
551000
Annuals > 3 > balance Sheet > total Assets
36605000
Annuals > 3 > balance Sheet > payables
4871000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
6108000
Annuals > 3 > balance Sheet > equity
30497000
Annuals > 3 > cash Flow > net Income
-32467000
Annuals > 3 > cash Flow > depreciation
42000
Annuals > 3 > cash Flow > change In Working Capital
-2450000
Annuals > 3 > cash Flow > cash From Operations
-32892000
Annuals > 3 > cash Flow > capital Expenditures
11000
Annuals > 3 > cash Flow > cash From Investing
11462000
Annuals > 3 > cash Flow > cash From Financing
17368000
Annuals > 3 > cash Flow > net Change In Cash
-4062000
Annuals > 3 > ratios > PE
-19.482364764410228
Annuals > 3 > ratios > PB
0.05053898730366921
Annuals > 3 > ratios > ROE
-104.75784503393777
Annuals > 3 > ratios > ROA
-87.27769430405682
Annuals > 3 > ratios > FCF
-32903000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.6319351398995489
Valuation > metrics > PB
0.20199773424937875
Valuation > final Score
70
Valuation > verdict
79.8% Undervalued
Profitability > metrics > ROE
-12.157092043073625
Profitability > metrics > ROA
-11.833617909315121
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11796520976465429
Risk > metrics > Interest Coverage
-5.463730569948186
Risk > final Score
38
Risk > verdict
High
Liquidity > metrics > Current Ratio
15.401022644265888
Liquidity > metrics > Quick Ratio
15.401022644265888
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
49
Prev Risks > 1
80
Prev Risks > 2
-23
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:33:19.423Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-01
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.75
Earnings History > 0 > eps Difference
0.75
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-26
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.33
Earnings History > 1 > eps Estimate
-0.79
Earnings History > 1 > eps Difference
0.46
Earnings History > 1 > surprise Percent
58.2278
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-28
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.63
Earnings History > 2 > eps Estimate
-0.83
Earnings History > 2 > eps Difference
0.2
Earnings History > 2 > surprise Percent
24.0964
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-22
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.62
Earnings History > 3 > eps Estimate
-0.89
Earnings History > 3 > eps Difference
0.27
Earnings History > 3 > surprise Percent
30.3371
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.94
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-20
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-2.3074
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-23
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.1332
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-30
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.98
Earnings History > 7 > eps Estimate
-0.32
Earnings History > 7 > eps Difference
-0.66
Earnings History > 7 > surprise Percent
-206.25
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-29
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.98
Earnings History > 8 > eps Estimate
-0.32
Earnings History > 8 > eps Difference
-0.66
Earnings History > 8 > surprise Percent
-206.25
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-22
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.24
Earnings History > 9 > eps Estimate
-0.27
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
11.1111
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.95
Earnings History > 10 > eps Estimate
-0.34
Earnings History > 10 > eps Difference
-0.61
Earnings History > 10 > surprise Percent
-179.4118
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-06-01
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-1.09
Earnings History > 11 > eps Estimate
-1.5
Earnings History > 11 > eps Difference
0.41
Earnings History > 11 > surprise Percent
27.3333
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-29
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.1
Earnings History > 12 > eps Estimate
-0.14
Earnings History > 12 > eps Difference
0.04
Earnings History > 12 > surprise Percent
28.5714
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-16
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.21
Earnings History > 13 > eps Estimate
-0.16
Earnings History > 13 > eps Difference
-0.05
Earnings History > 13 > surprise Percent
-31.25
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.15
Earnings History > 14 > eps Estimate
-0.24
Earnings History > 14 > eps Difference
0.09
Earnings History > 14 > surprise Percent
37.5
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-02
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.3
Earnings History > 15 > eps Estimate
-0.3
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2021-12-31
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.3
Earnings History > 16 > eps Estimate
-0.3
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-08
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.31
Earnings History > 17 > eps Estimate
-0.36
Earnings History > 17 > eps Difference
0.05
Earnings History > 17 > surprise Percent
13.8889
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-05
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.33
Earnings History > 18 > eps Estimate
-0.38
Earnings History > 18 > eps Difference
0.05
Earnings History > 18 > surprise Percent
13.1579
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-13
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.38
Earnings History > 19 > eps Estimate
-0.38
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
0
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-18
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.48
Earnings History > 20 > eps Estimate
-0.36
Earnings History > 20 > eps Difference
-0.12
Earnings History > 20 > surprise Percent
-33.3333
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-12
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.32
Earnings History > 21 > eps Estimate
-0.3
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-6.6667
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-06
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.26
Earnings History > 22 > eps Estimate
-0.32
Earnings History > 22 > eps Difference
0.06
Earnings History > 22 > surprise Percent
18.75
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-14
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.29
Earnings History > 23 > eps Estimate
-0.37
Earnings History > 23 > eps Difference
0.08
Earnings History > 23 > surprise Percent
21.6216
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-12
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.39
Earnings History > 24 > eps Estimate
-0.34
Earnings History > 24 > eps Difference
-0.05
Earnings History > 24 > surprise Percent
-14.7059
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-06
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.21
Earnings History > 25 > eps Estimate
-0.29
Earnings History > 25 > eps Difference
0.08
Earnings History > 25 > surprise Percent
27.5862
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-05
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.2
Earnings History > 26 > eps Estimate
-0.22
Earnings History > 26 > eps Difference
0.02
Earnings History > 26 > surprise Percent
9.0909
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-07
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.17
Earnings History > 27 > eps Estimate
-0.2
Earnings History > 27 > eps Difference
0.03
Earnings History > 27 > surprise Percent
15
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-13
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.18
Earnings History > 28 > eps Estimate
-0.13
Earnings History > 28 > eps Difference
-0.05
Earnings History > 28 > surprise Percent
-38.4615
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-05
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.05
Earnings History > 29 > eps Estimate
-0.14
Earnings History > 29 > eps Difference
0.09
Earnings History > 29 > surprise Percent
64.2857
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-02
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.17
Earnings History > 30 > eps Estimate
-0.16
Earnings History > 30 > eps Difference
-0.01
Earnings History > 30 > surprise Percent
-6.25
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-09
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.17
Earnings History > 31 > eps Estimate
-0.24
Earnings History > 31 > eps Difference
0.07
Earnings History > 31 > surprise Percent
29.1667
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-13
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.27
Earnings History > 32 > eps Estimate
-0.22
Earnings History > 32 > eps Difference
-0.05
Earnings History > 32 > surprise Percent
-22.7273
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-09
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.23
Earnings History > 33 > eps Estimate
-0.25
Earnings History > 33 > eps Difference
0.02
Earnings History > 33 > surprise Percent
8
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-07-31
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
BeforeMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.22
Earnings History > 34 > eps Estimate
-0.27
Earnings History > 34 > eps Difference
0.05
Earnings History > 34 > surprise Percent
18.5185
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-15
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
BeforeMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.26
Earnings History > 35 > eps Estimate
-0.38
Earnings History > 35 > eps Difference
0.12
Earnings History > 35 > surprise Percent
31.5789
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-23
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
BeforeMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.4
Earnings History > 36 > eps Estimate
-0.3
Earnings History > 36 > eps Difference
-0.1
Earnings History > 36 > surprise Percent
-33.3333
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-11-07
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
BeforeMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.34
Earnings History > 37 > eps Estimate
-0.39
Earnings History > 37 > eps Difference
0.05
Earnings History > 37 > surprise Percent
12.8205
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-08-03
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
BeforeMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.39
Earnings History > 38 > eps Estimate
-0.35
Earnings History > 38 > eps Difference
-0.04
Earnings History > 38 > surprise Percent
-11.4286
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-05-16
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
BeforeMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.36
Earnings History > 39 > eps Estimate
-0.33
Earnings History > 39 > eps Difference
-0.03
Earnings History > 39 > surprise Percent
-9.0909
Earnings History > 40 > period
2015-12-31
Earnings History > 40 > report Date
2016-03-22
Earnings History > 40 > date
2015-12-31
Earnings History > 40 > before After Market
BeforeMarket
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.29
Earnings History > 40 > eps Estimate
-0.28
Earnings History > 40 > eps Difference
-0.01
Earnings History > 40 > surprise Percent
-3.5714
Earnings History > 41 > period
2015-09-30
Earnings History > 41 > report Date
2015-11-09
Earnings History > 41 > date
2015-09-30
Earnings History > 41 > before After Market
BeforeMarket
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.23
Earnings History > 41 > eps Estimate
-0.29
Earnings History > 41 > eps Difference
0.06
Earnings History > 41 > surprise Percent
20.6897
Earnings History > 42 > period
2015-06-30
Earnings History > 42 > report Date
2015-08-13
Earnings History > 42 > date
2015-06-30
Earnings History > 42 > before After Market
BeforeMarket
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.21
Earnings History > 42 > eps Estimate
-0.25
Earnings History > 42 > eps Difference
0.04
Earnings History > 42 > surprise Percent
16
Earnings History > 43 > period
2015-03-31
Earnings History > 43 > report Date
2015-05-13
Earnings History > 43 > date
2015-03-31
Earnings History > 43 > before After Market
AfterMarket
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.22
Earnings History > 43 > eps Estimate
-0.36
Earnings History > 43 > eps Difference
0.14
Earnings History > 43 > surprise Percent
38.8889
Earnings History > 44 > period
2014-12-31
Earnings History > 44 > report Date
2015-03-31
Earnings History > 44 > date
2014-12-31
Earnings History > 44 > before After Market
BeforeMarket
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.15
Earnings History > 44 > eps Estimate
-0.35
Earnings History > 44 > eps Difference
0.2
Earnings History > 44 > surprise Percent
57.1429
Earnings History > 45 > period
2014-09-30
Earnings History > 45 > report Date
2014-11-12
Earnings History > 45 > date
2014-09-30
Earnings History > 45 > before After Market
BeforeMarket
Earnings History > 45 > currency
USD
Earnings History > 45 > eps Actual
-0.31
Earnings History > 45 > eps Estimate
-0.37
Earnings History > 45 > eps Difference
0.06
Earnings History > 45 > surprise Percent
16.2162
Earnings History > 46 > period
2014-06-30
Earnings History > 46 > report Date
2014-07-25
Earnings History > 46 > date
2014-06-30
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
USD
Earnings History > 46 > eps Actual
-0.15
Earnings History > 46 > eps Estimate
-0.35
Earnings History > 46 > eps Difference
0.2
Earnings History > 46 > surprise Percent
57.1429
Earnings History > 47 > period
2014-03-31
Earnings History > 47 > report Date
2014-05-14
Earnings History > 47 > date
2014-03-31
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
USD
Earnings History > 47 > eps Actual
-0.27
Earnings History > 47 > eps Estimate
-0.29
Earnings History > 47 > eps Difference
0.02
Earnings History > 47 > surprise Percent
6.8966
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGalmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications TipRanks
Read more →Galmed stock rises after patent grant for MASH combo therapy By Investing.com Investing.com South Africa
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
HOLD
Target Price:
$12
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 1.42% of the total shares of Galmed Pharmaceuticals Ltd
1.
Morgan Stanley - Brokerage Accounts(0.6127%)
since
2025/06/30
2.
Schonfeld Strategic Advisors LLC(0.4233%)
since
2025/06/30
3.
CAMBRIDGE Invest RESEARCH ADVISORS, INC.(0.1849%)
since
2025/06/30
4.
UBS Group AG(0.126%)
since
2025/06/30
5.
SBI Securities Co Ltd(0.0386%)
since
2025/06/30
6.
Macquarie Healthcare I(0.031%)
since
2025/07/31
7.
Uma Financial Services Inc(0.0004%)
since
2025/06/30
8.
TSFG, LLC(0.0003%)
since
2025/03/31
9.
Federation des caisses Desjardins du Quebec(0.0003%)
since
2025/06/30
10.
Wells Fargo & Co(0.0002%)
since
2025/06/30
11.
Advisor Group Holdings, Inc.(0.0001%)
since
2025/06/30
12.
Hanson Mcclain Inc(0%)
since
2025/06/30
13.
TD Waterhouse Canada Inc(0%)
since
2025/06/30
14.
ZRC WEALTH MANAGEMENT, LLC(0%)
since
2025/06/30
15.
Dogwood Wealth Management LLC(0%)
since
2025/06/30
16.
Tower Research Capital LLC(0%)
since
2025/03/31
17.
Virtu Financial LLC(0%)
since
2025/06/30
18.
TWO SIGMA SECURITIES, LLC(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
-0.75
Date
2025-09-30
EPS Actual
-0.33
EPS Estimate
-0.79
EPS Difference
0.46
Surprise Percent
58.2278%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.